1. Home
  2. SEPN vs KNOP Comparison

SEPN vs KNOP Comparison

Compare SEPN & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • KNOP
  • Stock Information
  • Founded
  • SEPN 2022
  • KNOP 2013
  • Country
  • SEPN United States
  • KNOP United Kingdom
  • Employees
  • SEPN N/A
  • KNOP N/A
  • Industry
  • SEPN
  • KNOP Marine Transportation
  • Sector
  • SEPN
  • KNOP Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • KNOP Nasdaq
  • Market Cap
  • SEPN 311.6M
  • KNOP 254.2M
  • IPO Year
  • SEPN 2024
  • KNOP 2013
  • Fundamental
  • Price
  • SEPN $6.69
  • KNOP $6.68
  • Analyst Decision
  • SEPN Buy
  • KNOP
  • Analyst Count
  • SEPN 4
  • KNOP 0
  • Target Price
  • SEPN $33.00
  • KNOP N/A
  • AVG Volume (30 Days)
  • SEPN 181.2K
  • KNOP 52.6K
  • Earning Date
  • SEPN 05-19-2025
  • KNOP 05-20-2025
  • Dividend Yield
  • SEPN N/A
  • KNOP 1.56%
  • EPS Growth
  • SEPN N/A
  • KNOP N/A
  • EPS
  • SEPN N/A
  • KNOP 0.18
  • Revenue
  • SEPN $1,075,000.00
  • KNOP $312,629,000.00
  • Revenue This Year
  • SEPN N/A
  • KNOP $5.04
  • Revenue Next Year
  • SEPN N/A
  • KNOP $1.00
  • P/E Ratio
  • SEPN N/A
  • KNOP $35.91
  • Revenue Growth
  • SEPN 611.92
  • KNOP 8.60
  • 52 Week Low
  • SEPN $4.17
  • KNOP $5.25
  • 52 Week High
  • SEPN $28.99
  • KNOP $9.11
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • KNOP 58.53
  • Support Level
  • SEPN N/A
  • KNOP $6.32
  • Resistance Level
  • SEPN N/A
  • KNOP $6.90
  • Average True Range (ATR)
  • SEPN 0.00
  • KNOP 0.22
  • MACD
  • SEPN 0.00
  • KNOP 0.01
  • Stochastic Oscillator
  • SEPN 0.00
  • KNOP 68.57

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests

KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.

Share on Social Networks: